medicube Exosome CICA Tea Tree Calming Toner Pads for Sensitive Skin with Centella Asiatica Help Reduce Redness & breakouts. Low-irritating & Hydrating Daily Care, Korean Skincare, Vegan (100 Pads)
$18.90
Related Products
L’Oreal Paris Skincare HydraFresh...
From the brand
NEW LAUNCH
BEST SELLERS
Package Dimensions : 3.7 x 3.66 x 3.31 inches; 10.58 ounces
Item model number : Pad
Date First Available : August 28, 2024
Manufacturer : Medicube
ASIN : B0DFG4MRC9
Country of Origin : Korea, Republic of
POWERFUL SOOTHING TONER PAD: 100 toner pads to hydrate, balance, and soften your skin with minimal irritation. Quick cooling and soothing effect.
ENRICHED WITH INNOVATIVE INGREDIENT : Contains exosome cica, Nano-sized ingredient smaller than pores with 5.3 times more powerful soothing effect than general cica. (*Clinical Trial Tested by ‘ICBIO Co., Ltd’ / Results may vary depending on individual skin types.)
HELPS SEBUM & PORE CARE : Perfect daily toner pad for pore & excess sebum care. Helps strengthen skin barrier and improve skin texture for glass glow skin.
DAILY TONER PAD : Low-irritating toner pad suitable for all skin type. Perfect daily toner pad for gentle & mild soothing care.
SUITABLE FOR TROUBLED SKIN: Exosome Cica & Tea Tree Leaf Water help to calm and quench troubled and textured areas.
Customers say
Customers find these wipes effective for skin care, noting their ability to clear blemishes and improve skin tone, while being gentle enough for sensitive skin. They are well-made, dirt wipes right off the face, and come with tongs for easy handling. While many customers report they don’t irritate their skin, some mention they can cause breakouts. Customers appreciate the hydration level, with one noting it’s not too drying, and find them convenient to use.
User Reviews
Be the first to review “medicube Exosome CICA Tea Tree Calming Toner Pads for Sensitive Skin with Centella Asiatica Help Reduce Redness & breakouts. Low-irritating & Hydrating Daily Care, Korean Skincare, Vegan (100 Pads)”
$18.90
There are no reviews yet.